Fisetin vs Spermidine
Two preclinical favorites with the same shape of problem. Excellent mouse data on both sides, and human evidence that is either not yet in or, for spermidine, already negative.
Short answer
Both rest mostly on animal and lab work, so the evidence cannot separate fisetin from spermidine. Fisetin is the one sold for senolytic use and anti-aging, while spermidine targets autophagy and longevity. Both are sold over the counter as supplements. In trials, spermidine showed no improvement in memory vs placebo after 12 months in the 100-person SmartAge RCT.
Fisetin
The most potent senolytic flavonoid in mice, with lifespan data — but the one human trial to report a clinical outcome (ROPE, knee osteoarthritis) was null; other senolytic-hypothesis trials remain unpublished.
Full Fisetin evidence reviewSpermidine
Autophagy + mouse-lifespan data and a striking diet-mortality association — but the best randomized human trial (memory) was null.
Full Spermidine evidence reviewFisetin vs Spermidine: head to head
- FDA status / approved use
Fisetin
Sold as a dietary supplement, not an approved drug; senolytic use is investigationalSpermidine
Sold as a supplement, usually wheat-germ extract- Marketed for
Fisetin
Senolytic, anti-agingSpermidine
Autophagy, longevity- Outcome areas
Fisetin
Cellular senescence; Longevity / lifespan; Joint / bone healthSpermidine
Longevity / lifespan; Cognitive function / memory- Evidence grade
Fisetin
Preclinical / minimalSpermidine
Preclinical / minimal- How it works
Fisetin
Senolytic: clears senescent 'zombie' cells, shown mainly in miceSpermidine
Induces autophagy, the cell's recycling of damaged components- Route and dosing
Fisetin
Oral supplement, often taken in high intermittent dosesSpermidine
Oral supplement; trials used 0.9 mg/day to 1.2 mg/day- Headline human result
Fisetin
No significant benefit for knee pain, function or cartilage at three months in the 2025 ROPE osteoarthritis RCTSpermidine
No improvement in memory vs placebo after 12 months in the 100-person SmartAge RCT- Strongest evidence
Fisetin
Mouse senolytic, EBioMedicine 2018. Little or no controlled human outcome data for the marketed useFisetin evidence reviewPubMed 30279143Spermidine
Mouse lifespan, Nat Med 2016. Little or no controlled human outcome data for the marketed useSpermidine evidence reviewPubMed 27841876- Key safety signal
Fisetin
Looks safe as a food compound; long-term safety of high senolytic doses is not establishedSpermidine
No differences from placebo at low doses over months; long-term, higher-dose safety not established- How it is obtained
Fisetin
Over the counter as a dietary supplementSpermidine
Over the counter as a dietary supplement
| Fisetin | Spermidine | |
|---|---|---|
| FDA status / approved use | Sold as a dietary supplement, not an approved drug; senolytic use is investigational | Sold as a supplement, usually wheat-germ extract |
| Marketed for | Senolytic, anti-aging | Autophagy, longevity |
| Outcome areas | Cellular senescence; Longevity / lifespan; Joint / bone health | Longevity / lifespan; Cognitive function / memory |
| Evidence grade | Preclinical / minimal | Preclinical / minimal |
| How it works | Senolytic: clears senescent 'zombie' cells, shown mainly in mice | Induces autophagy, the cell's recycling of damaged components |
| Route and dosing | Oral supplement, often taken in high intermittent doses | Oral supplement; trials used 0.9 mg/day to 1.2 mg/day |
| Headline human result | No significant benefit for knee pain, function or cartilage at three months in the 2025 ROPE osteoarthritis RCT | No improvement in memory vs placebo after 12 months in the 100-person SmartAge RCT |
| Strongest evidence | Mouse senolytic, EBioMedicine 2018. Little or no controlled human outcome data for the marketed useFisetin evidence reviewPubMed 30279143 | Mouse lifespan, Nat Med 2016. Little or no controlled human outcome data for the marketed useSpermidine evidence reviewPubMed 27841876 |
| Key safety signal | Looks safe as a food compound; long-term safety of high senolytic doses is not established | No differences from placebo at low doses over months; long-term, higher-dose safety not established |
| How it is obtained | Over the counter as a dietary supplement | Over the counter as a dietary supplement |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- Preclinical / minimal:
- Evidence is largely animal, in-vitro, or anecdotal. Little or no controlled human outcome data for the marketed use.
Our verdict
Both are graded preclinical, and honestly so. Fisetin cleared senescent cells and extended lifespan in old mice, with an independent study finding reduced frailty and better grip strength in aged but not young mice, yet no published human trial tests the senolytic claim and those studies are still ongoing. Spermidine has mouse lifespan and cardiac data tied directly to autophagy plus a striking association between higher dietary intake and lower mortality, but that association is observational and confounded by a generally healthier diet, and the 12-month SmartAge trial in 100 older adults found no effect on its primary memory endpoint. The practical difference is that spermidine has been put to a rigorous randomized test and failed it, while fisetin has not been tested yet; the two have not been compared directly.
Fisetin fits if
Someone betting early on the senolytic hypothesis who understands that every efficacy claim behind it is currently animal data.
Spermidine fits if
Someone who prefers a compound with a clean human safety record at the low doses studied and a real, if confounded, population-level mortality signal.
Fisetin vs Spermidine: common questions
- Is either fisetin or spermidine FDA-approved?
- No. Fisetin is sold as a dietary supplement, not an approved drug; senolytic use is investigational. Spermidine is sold as a supplement, usually wheat-germ extract.
- Which has stronger human evidence, fisetin or spermidine?
- Neither. Both are graded preclinical / minimal, with little or no controlled human outcome data for the marketed use. The key source for fisetin is mouse senolytic, EBioMedicine 2018; for spermidine, it is mouse lifespan, Nat Med 2016.
- What are the main safety concerns with fisetin and spermidine?
- Fisetin looks safe as a food compound; long-term safety of high senolytic doses is not established. Spermidine has no differences from placebo at low doses over months; long-term, higher-dose safety not established.
Key studies behind each
Fisetin
- Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. (2018). Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. PubMed 30279143
- Murray KO, Mahoney SA, Ludwig KR, et al. (2025). Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging. Aging Cell. PubMed 40437670
- Silva M, Wacker DA, Driver BE, et al. (2024). Senolytics To slOw Progression of Sepsis (STOP-Sepsis) in elderly patients: Study protocol for a multi-center, randomized, adaptive allocation clinical trial. Trials. PubMed 39434114
- Ji J, Crespi CM, Yee L, et al. (2026). A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design. Ther Adv Med Oncol. PubMed 41835341
Spermidine
- Eisenberg T, Abdellatif M, Schroeder S, et al. (2016). Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. PubMed 27841876
- Kiechl S, Pechlaner R, Willeit P, et al. (2018). Higher spermidine intake is linked to lower mortality: a prospective population-based study. Am J Clin Nutr. PubMed 29955838
- Wirth M, Benson G, Schwarz C, et al. (2018). The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial. Cortex. PubMed 30388439
- Schwarz C, Benson GS, Horn N, et al. (2022). Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Netw Open. PubMed 35616942
The full evidence reviews
- Fisetin: a powerful senolytic in mice, unproven in humans
A dietary flavonoid that's the most potent senolytic of its class and extends lifespan in mice — but the human trials that would test the senolytic claim are still ongoing, with no published outcomes.
Updated August 2026
- Spermidine: a great longevity story, still waiting on the trials
A polyamine that induces autophagy, extends lifespan in mice, and tracks with lower mortality in population studies — but the association is observational, and the best human trial found no effect.
Updated August 2026